Family Care Hospitals Ltd
Incorporated in 1994, Family Care Hospitals Ltd is in the business of providing Healthcare Services.[1]
- Market Cap ₹ 19.0 Cr.
- Current Price ₹ 3.52
- High / Low ₹ 6.94 / 3.37
- Stock P/E
- Book Value ₹ 1.51
- Dividend Yield 0.00 %
- ROCE 79.2 %
- ROE 85.5 %
- Face Value ₹ 10.0
Pros
- Company has a good return on equity (ROE) track record: 3 Years ROE 41.1%
- Debtor days have improved from 219 to 93.3 days.
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -9.83% over past five years.
- Promoter holding is low: 18.5%
- Promoters have pledged or encumbered 61.7% of their holding.
- Working capital days have increased from 269 days to 402 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.01 | 0.07 | 1.07 | 1.80 | 5.19 | 14.19 | 13.25 | 35.36 | 42.07 | 42.04 | 40.01 | 7.90 | 0.17 | |
| 0.35 | 0.24 | 0.86 | 1.54 | 3.84 | 12.73 | 10.98 | 27.18 | 33.37 | 33.59 | 33.12 | -21.33 | 6.66 | |
| Operating Profit | -0.34 | -0.17 | 0.21 | 0.26 | 1.35 | 1.46 | 2.27 | 8.18 | 8.70 | 8.45 | 6.89 | 29.23 | -6.49 |
| OPM % | -3,400.00% | -242.86% | 19.63% | 14.44% | 26.01% | 10.29% | 17.13% | 23.13% | 20.68% | 20.10% | 17.22% | 370.00% | -3,817.65% |
| 0.00 | -24.63 | 0.20 | 0.19 | 0.24 | 0.04 | -0.12 | -0.28 | 0.30 | 0.98 | 3.19 | -71.71 | 2.16 | |
| Interest | 0.00 | 0.00 | 0.01 | 0.01 | 0.12 | 0.51 | 0.84 | 0.83 | 0.50 | 0.60 | 0.53 | 0.86 | 0.33 |
| Depreciation | 0.00 | 0.03 | 0.38 | 0.25 | 0.39 | 0.94 | 1.28 | 1.42 | 1.44 | 1.41 | 1.42 | 1.13 | 0.93 |
| Profit before tax | -0.34 | -24.83 | 0.02 | 0.19 | 1.08 | 0.05 | 0.03 | 5.65 | 7.06 | 7.42 | 8.13 | -44.47 | -5.59 |
| Tax % | 0.00% | 0.00% | 0.00% | 21.05% | 20.37% | 60.00% | 33.33% | 27.96% | 26.35% | 29.11% | -54.24% | -0.72% | |
| -0.34 | -24.83 | 0.02 | 0.16 | 0.86 | 0.02 | 0.03 | 4.07 | 5.20 | 5.26 | 12.55 | -44.15 | -5.28 | |
| EPS in Rs | -3.41 | 0.00 | 0.02 | 0.12 | 0.00 | 0.00 | 0.56 | 0.71 | 0.97 | 2.32 | -8.17 | -0.98 | |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 6.17% | 5.13% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 60% |
| 5 Years: | -10% |
| 3 Years: | -43% |
| TTM: | -99% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 79% |
| 5 Years: | 186% |
| 3 Years: | 81% |
| TTM: | -114% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -5% |
| 5 Years: | -23% |
| 3 Years: | -37% |
| 1 Year: | -47% |
| Return on Equity | |
|---|---|
| 10 Years: | 37% |
| 5 Years: | 42% |
| 3 Years: | 41% |
| Last Year: | 86% |
Balance Sheet
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.00 | 32.10 | 32.10 | 32.10 | 32.10 | 32.10 | 32.10 | 32.10 | 32.10 | 54.01 | 54.01 | 54.01 | 54.01 |
| Reserves | -3.36 | -28.18 | -28.16 | -28.01 | -27.15 | -27.13 | -27.09 | -23.03 | -17.86 | -8.21 | 4.36 | -40.56 | -45.86 |
| 0.41 | 0.56 | 0.56 | 0.10 | 0.28 | 5.60 | 9.53 | 5.50 | 4.26 | 4.32 | 3.65 | 3.39 | 4.85 | |
| 0.01 | 0.04 | 0.08 | 1.31 | 4.66 | 3.22 | 2.59 | 5.81 | 21.34 | 24.46 | 7.94 | 29.26 | 32.50 | |
| Total Liabilities | 0.06 | 4.52 | 4.58 | 5.50 | 9.89 | 13.79 | 17.13 | 20.38 | 39.84 | 74.58 | 69.96 | 46.10 | 45.50 |
| 0.00 | 1.74 | 1.84 | 2.44 | 7.24 | 8.61 | 9.52 | 8.01 | 6.82 | 6.93 | 5.95 | 4.00 | 3.54 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.60 | 0.86 | 0.06 | 0.04 | 0.09 | 0.09 | 0.09 | 0.06 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 0.06 | 2.78 | 2.74 | 2.46 | 1.79 | 5.12 | 7.57 | 12.28 | 32.93 | 67.56 | 63.95 | 42.10 | 41.96 | |
| Total Assets | 0.06 | 4.52 | 4.58 | 5.50 | 9.89 | 13.79 | 17.13 | 20.38 | 39.84 | 74.58 | 69.96 | 46.10 | 45.50 |
Cash Flows
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.35 | -0.07 | 0.34 | 0.46 | 3.04 | -4.12 | -1.29 | 3.90 | 1.68 | -5.26 | -0.37 | -17.32 | |
| 0.00 | -1.77 | -0.48 | -1.45 | -5.45 | -1.51 | -2.32 | -0.26 | -0.25 | -1.54 | -0.41 | 0.65 | |
| 0.40 | 4.52 | 0.00 | 0.78 | 0.26 | 5.86 | 4.75 | -4.82 | -1.67 | 25.87 | -1.04 | -0.55 | |
| Net Cash Flow | 0.05 | 2.68 | -0.14 | -0.21 | -2.14 | 0.23 | 1.14 | -1.17 | -0.23 | 19.08 | -1.83 | -17.22 |
Ratios
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 64.56 | 112.67 | 93.21 | 186.19 | 251.96 | 310.35 | 93.33 |
| Inventory Days | 149.08 | 29.44 | 3.74 | 6.18 | 16.46 | |||||||
| Days Payable | 976.76 | 211.94 | 382.44 | 386.99 | 112.66 | |||||||
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 64.56 | -715.01 | -89.29 | -192.52 | -128.86 | 214.15 | 93.33 |
| Working Capital Days | -14,600.00 | -2,920.00 | -160.33 | -271.72 | -311.55 | -145.85 | -16.25 | 54.71 | 99.86 | 149.42 | 254.98 | 402.42 |
| ROCE % | -2,266.67% | -3.97% | 0.67% | 4.60% | 25.48% | 7.09% | 8.04% | 46.58% | 45.78% | 23.40% | 15.44% | 79.25% |
Documents
Announcements
- Shareholder Meeting / Postal Ballot-Notice of Postal Ballot 18h
- Revised Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 22h
- Financial Result For Quarter Ended 31St December 2025 1d
-
Announcement under Regulation 30 (LODR)-Change in Management
1d - Q3 FY26 unaudited: ₹625.98 lakh nine-month loss; 18,677,500 warrants, ₹4.6694 crore received; director reappointments.
-
Board Meeting Outcome for Outcome For Board Meeting Dated 20Th January 2026
1d - Q3 results approved; reappointed three directors; received Rs4.66 crore on 18,677,500 share warrants; postal ballot.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1][2][3]
FCHL is in the business of providing healthcare products and services through integrating AI technology and traditional healthcare delivery systems. It has 150 beds, 30 specialities, 300 allied staff, and 40 ICU beds. The company is working closely with Ready Technologies, a unit of Onelife Capital Advisors Ltd (a promoter group company), to develop user-friendly software/ applications which it plans to market aggressively in India and abroad.